DOCSLIB.ORG

SABIN VACCINE REPORT the Newsletter of the Albert B

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
SABIN VACCINE REPORT the Newsletter of the Albert B SABIN VACCINE REPORT the newsletter of the Albert B. Sabin Vaccine Institute at Georgetown University Volume II, Number 1, March 1999 IN THIS ISSUE Gates donates $100 million for childrens vaccines Rotavirus vaccine developed The newly developed vaccine for BY JOHN CLYMER AND DIANE MYERS Decreasing the lag time intestinal disease could improve the health of over 500 million children Microsoft billionaires Bill and Melinda Gates have Why is the Gates Foundation program of such importance? made a $100 million gift to establish a program to acceler- New, life-saving vaccines generally are in broad use in in- worldwide. ate access to new vaccines for children in developing na- dustrialized countries several years before they become widely 1 tions. The goal of the Bill and Melinda Gates Children’s used in developing countries where the need is greatest. This Vaccine Program’s is to significantly reduce the time it cur- time lag in vaccine “uptake” is due to economic, logistical rently takes for vaccines to reach children living in poor coun- and other challenges. tries. “We have a social imperative to work together to The initiative is a program of the William H. Gates SPECIAL REPORT: MALARIA address this basic inequity,” said Bill Gates, trustee of the A report on the impact of malaria on Foundation and will Fiset photo by PATH/J. William H. Gates Foundation. global health, the search for a vaccine, be administered by Sabin Vaccine Institute chairman and the risks travelers face when the Program for H. R. “Shep” Shepherd ap- visiting malaria-endemic areas. Appropriate plauded Gates’ vision and the es- 2-5 Technology in tablishment of the Children’s Vac- Health (PATH). cine Program. “Vaccines are the Headquartered in most powerful tool available to Seattle, PATH will equalize the health of human be- work with the World ings in every corner of the Profile: Herbert Herscowitz Health world,” he said. “Enlightened Institute scientist combines career in Organization, leaders understand the power of research and teaching. UNICEF, the vaccines to help bring peace and 6 World Bank, the Phillip Russell (l), Suryanarayan Ramachandran, and James Maynard. opportunity to the most troubled Children’s Vaccine places in our world. Vaccines are Initiative, vaccine the microchip that will revolution- manufacturers, ize healthcare,” Shepherd de- governments and clared. Aerosol measles workshop nongovernmental organizations. The Children’s Vaccine Program will specifically support Researchers meet to dicuss PATH plans to focus on four recently developed ways to make the vaccines widely available to children in alternerative vaccine delivery systems. or about-to-be-marketed vaccines against respiratory, in- developing countries. It will not be used to buy the vac- 6 testinal and liver diseases. Global use of the vaccines could cines. reduce childhood deaths by 33%, representing 2.5 million The program will be managed by a Secretariat lives, and reduce liver cancer deaths by 75%. Two of the based at PATH, under the guidance of a Strategic Advisory vaccines prevent respiratory ailments caused by the bacte- Council that is composed of seven international experts in ria Haemophilus influenzae type b, or Hib, and strepto- vaccinology and vaccine introduction. Philip K. Russell, coccus pneumoniae; a third prevents rotavirus infection, founding president of the Albert B. Sabin Vaccine Institute, which causes severe diarrhea;, and the fourth vaccine be- is a member of the Strategic Advisory Council. He lauds the ing considered prevents hepatitis B, a viral liver disease. Gates’ program as a “very exciting development in the field In the United States, vaccines for Hib and hepati- of international health.” tis B are part of the recommended childhood immuniza- tion schedule, and vaccines for rotavirus and streptococ- An entreprenurial approach cus pneumonia are expected to become part of the recom- mended immunization schedule soon. According to Russell, who has years of experience continued on page 7 Rotavirus vaccine could benefit 500 million children BY RACHEL LIBERATORE veloped by Albert Z. Kapikian of the Laboratory of Infectious Diseases (LID) at the National Institute of Allergy and Infectious Although rotavirus infections affect 300-500 million Diseases (NIAID) along with other colleagues at the National children every year, this disease has only recently provoked the Institutes of Health. The vaccine is manufactured by Wyeth- kind of intense research investment one might expect for such Ayerst Laboratories at a cost of approximately $38 per dose. a ubiquitous affliction. Unfortunately, the reason for this is Ideally, a vaccine is supposed to save society money the same for many diseases whose primary because the price of the vaccine is less than the cost of treating the targets are nations in which the average per disease. From the perspective of the health care capita health expenditure hovers just around system, however, the cost of the vaccine should $10. In the case of rotaviruses, this trend of be high enough that the system does not lose apathy toward diseases in developing nations money due to the decreased need for treatment. was turned around following studies demon- A study headed by Roger I. Glass, chief of the strating that this disease actually leads to a sig- Viral Gastroenteritis Section at the Centers for nificant amount of health care expenditure in Disease Control and Prevention (CDC), deter- developed countries, where the ability to pay mined that a rotavirus vaccine would be cost- for preventive and prophylactic treatments is effective to both society and the health care sys- much greater. Once a lucrative market was es- tem in the United States if the cost fell within a tablished, a vaccine for rotavirus was soon de- range of $9-$51 per dose. Glass’s pivotal study veloped and has been recently licensed. is widely credited with providing the impetus Rotaviruses are the infectious agents photo by Erica Seiguer for the pharmaceutical industry to devote re- sources to rotavirus vaccine development, which responsible for most cases of childhood diar- Roger Glass rhea. Ninety-five percent of children worldwide ultimately led to the approval of Rotashield™. are exposed to rotaviruses between the ages of three and five, According to Glass, although “there is a clear need for though in developing nations initial exposure is usually within rotavirus vaccine for all children, without the demand and money the first year of life. Such intestinal infections are particularly of the developed countries, it is unlikely that any country would dangerous in children because they are more likely than adults to be interested.” As evidence, he points to the failures of new chol- suffer from dehydration, especially if they have previously com- era and typhoid vaccines, needed in developing countries but promised health. now priced and sold for travelers—a tiny and nonviable market. In August 1998, the Food and Drug Administration (FDA) approved the first rotavirus vaccine since the discovery of continued on page 7 Sabin Vaccine Report Vaccine Sabin Institute Vaccine Sabin Albert B. at Georgetown University NW Road, Suite 154, 4000 Reservoir Building D, Washington, DC 20007-2145 rotaviruses in 1973. The vaccine, called RotaShield™, was de- Malaria Report Malaria Report Malaria Report Malaria Report Malaria Report Mala SABIN VACCINE REPORT March 1999 ALBERT B. SABIN VACCINE INSTITUTE Controlling Malaria Will Require an International Effort AT GEORGETOWN UNIVERSITY BY HOWARD ENGERS, PHD CHAIRMAN Malaria alone accounts for over 2% of the total global disease burden and five times this figure in Africa, H.R. Shepherd ranking third among major infectious disease threats. There are an estimated 300-500 million cases of malaria each year, resulting in over 1 million deaths, mainly of children under five years old in Africa. Augmented by the more recent EXECUTIVE VICE PRESIDENT impact of globalization, the disease is often linked to poverty, the movement of refugees or populations seeking work Edward Neiss MD PhD and to environmental change, including forestry, mining and water development projects. We can conquer malaria. But to do so, will require a concerted global effort, involving Private and Public SENIOR VICE PRESIDENT sector participation and that of civil society. All manner of resources will need to be brought to bear. Better ways must Joseph A. Bellanti MD be found to apply existing control methods. Improved tools must be developed and solutions need to be identified to circumvent and combat emerging problems including social/political unrest, the widespread resistance of the malaria BOARD OF DIRECTORS parasite to existing drugs and the potential change in the distribution and incidence of malaria due to anthropogenic Jason S. Berman climate change. Zev Braun Reflecting its prominent status as a global killer, malaria has been a priority for World Health Organization Kenneth L. Dretchen PhD (WHO) since its founding in 1948. A revised WHO Global Malaria Control Strategy was adopted at the Amsterdam Robert E. Fuisz MD Summit of 1992, based on a renewed global commitment to malaria control. Recognizing the widespread political E. Andrews Grinstead III desire that has been building over this decade, the new Director General of WHO, Dr G.H. Brundtland, declared upon Jerome Jacobson taking office in July 1998 that there should be a deeper commitment to win the fight against malaria. Greater financial David J. Meiselman Esq resources and a higher visibility for malaria control activities would be necessary. This declaration led four UN-System Lewis A. Miller agencies (UNDP, UNICEF, WHO and the World Bank) to launch Roll Back Malaria (RBM) on 30 October 1998. Louis Padovano SJ MD The RBM project, co-ordinated by WHO, aims to: 1) support governments and partners; 2) improve technical effi- Maj. Gen. Philip K. Russell MD ciency and capacity, including the development of new methods, new tools and capacity strengthening in the malaria Heloisa Sabin endemic countries; 3) to improve resource allocation, utilization and mobilization.
Load more

Recommended publications
  • TESTIMONY Peter J. Hotez MD, Phd President, Sabin Vaccine Institute
    TESTIMONY Peter J. Hotez MD, PhD President, Sabin Vaccine Institute “The Growing Threat of Cholera and Other Diseases in the Middle East” Subcommittee on Africa, Global Health, Global Human Rights, and International Organizations Committee on Foreign Affairs United States House of Representatives March 2, 2016 Mr. Chairman and Members of the Subcommittee, thank you for the opportunity to speak with you today. I am Peter Hotez, a biomedical scientist and pediatrician. I am the dean of the National School of Tropical Medicine at Baylor College of Medicine and also the Texas Children’s Hospital Endowed Chair in Tropical Pediatrics based at the Texas Medical Center in Houston. I am also past president of the American Society of Tropical Medicine and Hygiene, and currently serve as President of the Sabin Vaccine Institute, a non-profit which develops vaccines for neglected tropical diseases (NTDs) through a product development partnership (PDP) model. This year I am also serving as US Science Envoy for the State Department and White House Office of Science and Technology Policy focusing on the urgency to develop vaccines for diseases that are emerging in the Middle East and North Africa due to the breakdowns in health systems in the ISIS occupied conflict zones in Syria, Iraq, Libya, and also Yemen. In my submitted written testimony I highlighted some of the successes in US global health policy, many of which can be attributed to the hard work of this Subcommittee working hand in glove with two presidential administrations since 2000. I cite evidence from the Global Burden of Disease Study (GBD) that brings together hundreds of scientists - I am also a part of this - who are measuring the impact of large scale global health programs.
    [Show full text]
  • Worksafe Bulletin Avian Influenza
    Work Sa fe Bu l l e t in Avian influenza — Protect against infection and prevent the virus from spreading According to the BC Centre for Disease Control, avian influenza (flu) has been transmitted in rare cases from birds to humans and from humans to humans. Because of this possible health risk, it is important to protect humans against exposure to avian flu. What is avian influenza? An outbreak will also require the use of safe work procedures and personal protective equipment Avian flu is a viral disease that affects poultry (PPE), including respiratory protection for workers. and, in some cases, humans. There are several strains of avian flu, which are closely related to It is very important that no birds or materials human influenza. be taken from suspected infection areas. All materials, equipment, and people coming out of such areas must be decontaminated. Do not enter What if an outbreak occurs contaminated areas, if possible. If you must enter, on my farm? follow the direction of CFIA. If you suspect a bird in your flock is infected with avian flu, you must take immediate action. How can I protect myself and others Every farm in British Columbia is required to follow during an outbreak? the BC Poultry Biosecurity Reference Guide. Implement your SOP for self-quarantine, use This document describes mandatory biosecurity enhanced PPE, and follow instructions from CFIA protocols, including how to develop a standard and the Fraser Health Authority. Review these operating procedure (SOP) for self-quarantine. items with your workers and make sure they have Make sure everyone follows your enhanced any necessary training.
    [Show full text]
  • Sabin in the News Recent Scientific Articles Sabin Vaccine Institute
    Home About Us News & Resources Support Sabin Sabin in the News October 2011 The Sabin Report | Volume 13 Issue 2 New York Times article featuring Dr. Peter Hotez's new study on increased Sabin Vaccine Institute Establishes a Houston prevalence of NTDs in Europe. Office Drs. Ciro de Quadros and In September 2011, the Zulfiqar Bhutta highlight Sabin Vaccine Institute the dire need for a dengue established offices in vaccine in an opinion Houston, Texas in the piece for GlobalPost. heart of the city's Texas Medical Center (TMC). The In an interview on Voice of new facilities will house the America Dr. Peter Hotez Sabin Vaccine Institute & focused on NTDs in Sub- Texas Children's Hospital Saharan Africa. Center for Vaccine Development, which will be An article by Dr. Neeraj operated in partnership Mistry was featured in a with Baylor College of special supplemental Medicine Department of section of the USA today, Pediatrics. Sabin Dr. Hotez and team at Sabin's new Houston facility titled "Neglected Diseases President, Dr. Peter J. in Developing Nations". Hotez will direct the new center. In an op-ed for the Houston Chronicle, Dr. The new space includes offices and laboratories through which the Peter Hotez writes about Sabin Vaccine Institute Product Development Partnership (PDP) will the establishment of the advance and strengthen its collaborative work in the field of vaccine new School of Tropical biotechnology. The change is the result of a year-long plan to expand Medicine at Baylor College the scope and depth of the Sabin PDP's partnership and to enhance of Medicine.
    [Show full text]
  • The Highly Pathogenic Avian Influenza A(H5N1) Virus: a Twenty-Year Journey of Narratives and (In)Secure Landscapes
    The Highly Pathogenic Avian Influenza A(H5N1) Virus: a twenty-year journey of narratives and (in)secure landscapes Philip Rolly Egert Dissertation submitted to the faculty of the Virginia Polytechnic Institute and State University in partial fulfillment of the requirements for the degree of Doctor of Philosophy In Science, Technology, and Society Barbara L. Allen (Chair) Daniel Breslau Bernice L. Hausman David C. Tomblin March 18, 2016 Falls Church, Virginia Keywords: H5N1, HPAI, highly pathogenic avian influenza virus, pandemic, social justice, bioterrorism, bioethics, biopower, tacit knowledge, dual-use dilemma, dual-use research of concern, emerging infectious disease Copyright Philip R. Egert The Highly Pathogenic Avian Influenza A(H5N1) Virus: a twenty-year journey of narratives and (in)secure landscapes Philip Rolly Egert ABSTRACT This dissertation is comprised of two manuscripts that explore various contestations and representations of knowledge about the highly pathogenic avian influenza H5N1virus. In the first manuscript, I explore three narratives that have been produced to describe the 20-year journey of the virus. The journey begins in 1996 when the virus was a singular localized animal virus but then over the next 20 years multiplied its ontological status through a (de)stabilized global network of science and politics that promoted both fears of contagion and politics of otherness. Written by and for powerful actors and institutions in the global North, the narratives focused on technical solutions and outbreak fears. In doing so, the narratives produced policies and practices of biopower that obscured alternative considerations for equity, social justice, and wellbeing for the marginalized groups most directly affected by the H5N1 virus.
    [Show full text]
  • Excerpted from the Hot Zone by Richard Preston
    The Hot Zone, by Richard Preston - Excerpt The Hot Zone captures the terrifying true story of an Ebola outbreak that made its way from the jungles of Africa to a research lab just outside of Washington, D.C. In the excerpt below, author Richard Preston describes the symptoms of this deadly virus as they appeared in one of its first known human victims. The headache begins, typically, on the seventh day after exposure to the agent. On the seventh day after his New Year’s visit to Kitum cave-January 8, 1980-Monet felt a throbbing pain behind his eyeballs. He decided to stay home from work and went to bed in his bungalow. The headache grew worse. His eyeballs ached, and then his temples began to ache, the pain seeming to circle around inside his head. It would not go away with aspirin, and then he got a severe backache. His housekeeper, Johnnie, was still on her Christmas vacation, and he had recently hired a temporary housekeeper. She tried to take care of him, but she really didn’t know what to do. Then, on the third day after his headache started, he became nauseated, spiked a fever, and began to vomit. His vomiting grew intense and turned into dry heaves. At the same time, he became strangely passive. His face lost all appearance of life and set itself into an expressionless mask, with the eyeballs fixed, paralytic, and staring. The eyelids were slightly droopy, which gave him a peculiar appearance, as if his eyes were popping out of his head and half closed at the same time.
    [Show full text]
  • Hot Zone Excerpt.Pdf
    This book describes events between 1967 and The second angel poured his bowl 1993. The incubation period of the viruses in this into the sea, and it became tike the blood book is less than twenty-four days. No one who of a deai-mon. suffered from any of the viruseJ or who was in contact with anyone suffering from them can catch -APOCALYPSE or spread the viruses outside of the incubation period. None of the living people referred to in this book suffer from a contagious disease. The viruses cannot surive independently for more than ten days unless the viruses ur" pr-es"*"d and frozen with special procedur"s arrd laboratory equipment. Thus none of the locations in Reston or the Washington, D.C., area described in this book is infective or dangerous. TO THE READEII This book is nonfiction. The story is true, and the people are real. I have occasionally changed the ,,Charles names of characters, including Monet,, and "Peter Cardinal." When I have changed a name, I state so in the text. The dialogue comes from the recollections of the participants, and has been extensively cross- checked. At certain moments in the story, I describe the stream of a person,s thoughts. In such instances, I am basing my narrative on interviews with the subjects in which they have recalled their thoughts often repeatedly, followed by fact- checking sessions in which the subjects confirmed their recollections. If you ask a person, ,,What were you thinking?" you may get an answer that is richer and more revealing of the human condition than any stream of thoughts a novelist could invent.
    [Show full text]
  • Viral Outbreak: the Science of Emerging Disease Lecture 4 – Solving SARS and Other Viral Mysteries Joe Derisi, Ph.D
    Viral Outbreak: The Science of Emerging Disease Lecture 4 – Solving SARS and other Viral Mysteries Joe Derisi, Ph.D. 1. Begin of Lecture 4 (0:16) [ANNOUNCER:] From the Howard Hughes Medical Institute. The 2010 Holiday Lectures on Science. This year's lectures, "Viral Outbreak: The Science of Emerging Disease", will be given by Dr. Joseph DeRisi, Howard Hughes Medical Institute investigator at the University of California, San Francisco, and by Dr. Eva Harris, Professor of Infectious Diseases at the University of California, Berkeley. The fourth lecture is titled Solving SARS and Other Viral Mysteries. And now to introduce our program, the President of the Howard Hughes Medical Institute, Dr. Robert Tjian 2. Welcome by HHMI President Dr. Robert Tjian (01:07) [DR. TJIAN:] Welcome back to this final presentation of this year's Holiday Lectures on Science. It's a great pleasure once again to introduce Joe DeRisi to give our fourth and last lecture in the series. Previously, Joe told us about how using bioengineering, computers, and molecular biology, he has been able to combine these tools for a potent approach to hunt for new viruses. In this lecture, Joe is going to show you how he can use his Virochip in real-time and in real life situations to discover and quickly diagnosis new viral outbreaks. Joe will also, I think, give us a glimpse of what the future in biotechnology holds towards the end of his talk. And now a brief video about Joe. 3. Profile of Dr. Joseph DeRisi (02:07) [DR. DERISI:] Science as we know it now is a highly interdisciplinary endeavor.
    [Show full text]
  • Peter Hotez, M.D., Ph.D. Biography
    Peter Hotez, MD, PhD, FASTMH, FAAP Peter J. Hotez, M.D., Ph.D., is professor of pediatrics and Molecular Virology and Microbiology at Baylor College of Medicine where he is also chief of a new Section of Pediatric Tropical Medicine and founding Dean of the National School of Tropical Medicine. In addition Prof. Hotez is the Texas Children's Hospital Endowed Chair of Tropical Pediatrics, and president of the Sabin Vaccine Institute. He will lead the new Sabin vaccine development program at Texas Children's Hospital and Baylor College of Medicine. He moves to BCM and Texas Children's from The George Washington University, where he has served as a Distinguished Research Professor and the Walter G. Ross Professor and Chair of the Department of Microbiology, Immunology and Tropical Medicine. Dr. Hotez is an internationally-recognized clinician and investigator in neglected tropical diseases and vaccine development. Diseases he studies include hookworm, schistosomiasis, Chagas disease, leishmaniasis, and malaria, among others, impacting hundreds of millions of children and adults worldwide. He obtained his undergraduate degree in molecular biophysics from Yale University in 1980, followed by a Ph.D. degree in biochemical parasitology from Rockefeller University in 1986 and a medical degree from Cornell University in 1987. He completed pediatric residency training at Massachusetts General Hospital from 1987 to 1989 and postdoctoral fellowship training in infectious diseases and molecular parasitology at Yale from 1989 to 1991. Dr. Hotez joined the Yale faculty as an assistant professor of pediatrics in 1992. He became an associate professor in 1995 before moving to the George Washington University as professor and chair in 2000.
    [Show full text]
  • Ebola, Emerging: the Limitations of Culturalist Discourses In
    Research Articles Ebola, Emerging: The Limitations of Culturalist Discourses in Epidemiology Jared Jones Yale University, New Haven, CT, USA Abstract In this paper, I offer a critique of the culturalist epidemiology that dominates the discourse of Ebola in both popular and international health spheres. Ebola has been exoticized, associated with “traditional” practices, local customs, and cultural “beliefs” and insinuated to be the result of African ig- QRUDQFHDQGEDFNZDUGQHVV,QGHHGUHLÀHGFXOWXUHLVUHFRQÀJXUHGLQWRD´ULVNIDFWRUµ$FFRXQWVRI WKHGLVHDVHSDLQW$IULFDQFXOWXUHDVDQREVWDFOH to prevention and epidemic control efforts, at times even linking the eruption of the disease to practices such as burial traditions or consumption of bushmeat. But this emphasis is misleading; the assumption of African “otherness,” rather than evidence, epidemiological or otherwise, under- pins dominant culturalist logics that “beliefs” motivate behaviors which increase the likelihood of Ebola’s emergence and spread. Conspicuously ab- VHQWIURPERWKSRSXODUDQGRIÀFLDOUKHWRULFKDVEHHQDWWHQWLRQWRODUJHUVWUXFWXUDOGHWHUPLQDQWVRI WKHFRXUVHRI (ERODHSLGHPLFV<HWJOREDOIRUFHV condition the emergence of Ebola far more than culture does. Inequality and inadequate provision of healthcare, entrenched and exacerbated by a legacy of colonialism, superpower geopolitics, and developmental neoliberalism, are responsible for much of Ebola’s spread. Certainly, structural force alone cannot account for the destruction Ebola has wreaked on the lives of victims and their families. Culture does matter. But the focus on culture comes at the expense of attention to sociopolitical and economic structures, obscuring the reality that global forces affect epidemics in Af- rica. In this paper, I seek to map the discursive contours of Ebola’s emergence, contextualize these trends within a larger debate about the role of anthropology in epidemiology, and question the simplistic link between culture and Ebola through a critical examination of structural-level forces.
    [Show full text]
  • {PDF} the Hot Zone Ebook, Epub
    THE HOT ZONE PDF, EPUB, EBOOK Richard Preston | 448 pages | 01 Aug 1995 | Bantam Doubleday Dell Publishing Group Inc | 9780385479561 | English | New York, United States The Hot Zone PDF Book Kyle Orman 6 episodes, James D'Arcy Both species, the human and the monkey, were in the presence of another life form, which was older and more powerful than either of them, and was a dweller in blood. Yes this is history written in the style of journalism and therefor for popular consumption. However I don't think it's crazy that the "winner" of viruses vs. That is a simple statement and around it revolves the larger story. The depth of research is apparent and thorough and while I did feel like I was learning while being A very scary and fast paced read that is all the more terrifying because it is true. This book continued to fuel the emerging diseases campaign. Jones reveals that at the time of the Marburg outbreak, he was inspecting monkeys in Entebbe that were to be exported to Europe. By thirty percent. Jahrling's analysis races up the chain of command. Retrieved July 31, Ben's Young Son 1 2 episodes, Later, while working on a dead monkey infected with Ebola virus, one of the gloves on the hand with the open wound tears, and she is almost exposed to contaminated blood, but does not get infected. Lloviu cuevavirus LLOV. Shem Musoke. The monster has not been slain and the good guys at best can regain some control. So totally pure. As she develops symptoms, Nurse Mayinga fears that her scholarship to study in Europe might be revoked.
    [Show full text]
  • Detection and Characterization of a Novel Bat-Borne Coronavirus in Singapore Using Multiple Molecular Approaches
    RESEARCH ARTICLE Lim et al., Journal of General Virology 2019;100:1363–1374 DOI 10.1099/jgv.0.001307 Detection and characterization of a novel bat-borne coronavirus in Singapore using multiple molecular approaches Xiao Fang Lim1,2, Chengfa Benjamin Lee3, Sarah Marie Pascoe3, Choon Beng How3, Sharon Chan3, Jun Hao Tan1, Xinglou Yang1,4, Peng Zhou4, Zhengli Shi4, October M. Sessions1,5,6, Lin-Fa Wang1, Lee Ching Ng2, Danielle E. Anderson1,* and Grace Yap2,* Abstract Bats are important reservoirs and vectors in the transmission of emerging infectious diseases. Many highly pathogenic viruses such as SARS-CoV and rabies-related lyssaviruses have crossed species barriers to infect humans and other animals. In this study we monitored the major roost sites of bats in Singapore, and performed surveillance for zoonotic pathogens in these bats. Screening of guano samples collected during the survey uncovered a bat coronavirus (Betacoronavirus) in Cynopterus brachyotis, commonly known as the lesser dog-faced fruit bat. Using a capture-enrichment sequencing platform, the full- length genome of the bat CoV was sequenced and found to be closely related to the bat coronavirus HKU9 species found in Leschenault’s rousette discovered in the Guangdong and Yunnan provinces. INTRODUctiON CoVs in general can cause disease in a variety of domestic and Infectious diseases continue to be a major threat to modern wild animals, as well as in humans, whereas alpha- and beta- society and coronaviruses (CoVs) are one of the most notable coronaviruses predominantly infect mammals. SARS-CoV virus families responsible for recent, highly pathogenic viral and MERS-CoV belong to the genus Betacoronavirus, under disease outbreaks.
    [Show full text]
  • A Critical Analysis of the Ebola and Marburg Viruses
    A Critical Analysis of the Ebola and Marburg Viruses A thesis submitted to the Miami University Honors Program in partial fulfillment of the requirements for University Honors by William F. Scully III May, 2004 Oxford, Ohio ii ABSTRACT A Critical Analysis of the Ebola and Marburg Viruses By William F. Scully III The Ebola and Marburg viruses have been identified as two of the most virulent pathogens to emerge in the past few decades. Every year, more information is collected about these viruses. However, because outbreaks have been so isolated and sporadic, and the viruses are so dangerous and difficult to work with in a laboratory setting, significant gaps and contradictions still exist in the information that has been obtained. The purpose of this thesis is to take a closer look at these viruses in order to fill in some of the gaps and correct some of the inaccurate information. Several different sources, including journals, texts, and other scholarly works, have been incorporated in order to produce a comprehensive analysis that covers a wide range of issues. The thesis begins by presenting the outbreak history of these two pathogens. The virus structures and classification status are then covered. Later in the work, other topics are discussed including diagnosis methods, transmission, viral pathology, and therapies. The thesis then discusses the progress that has been made in finding the natural reservoirs of the viruses. Finally, a brief analysis is included to conclude the work which discusses future developments and areas of research. iii iv A Critical Analysis of the Ebola and Marburg Viruses By William F.
    [Show full text]